<DOC>
	<DOCNO>NCT00159627</DOCNO>
	<brief_summary>The purpose study evaluate safety KW-3902IV compare placebo determine diuretic effect KW-3902IV compare placebo patient hospitalized volume overload due CHF refractory high dose diuretic therapy .</brief_summary>
	<brief_title>Dose Escalation Study KW-3902 Diuresis Subjects With Congestive Heart Failure ( CHF ) .</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Diuretics</mesh_term>
	<mesh_term>Rolofylline</mesh_term>
	<criteria>History CHF great 3 month , Receiving oral/IV diuretic therapy Hospitalized therapy HF edema respond diuretic therapy . Signs symptoms ongoing volume overload Myocardial infarction past 14 day Clinical evidence acute coronary syndrome cause worsen HF , Pregnant breastfeeding , Severe , uncorrected primary valvular disease , constrictive pericarditis , restrictive hypertrophic cardiomyopathy , Automated implant cardiac defibrillator ( AICD ) synchronization device implant within precede 7 day , Require mechanical ventilation , ultrafiltration , hemodialysis time enrollment , Deterioration due acute superimpose condition require therapy diuretic Symptomatic ventricular tachycardia , Severe concomitant primary hepatic disease , Severe pulmonary disease , Any concomitant lifethreatening disease , CVA precede 6 month , Hypotension , Participated another clinical trial within 30 day , Acute contrast nephropathy , Admitted heart transplant surgery heart transplant .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2008</verification_date>
	<keyword>heart failure , congestive</keyword>
	<keyword>diuretic</keyword>
</DOC>